FDA Warning Letter — Glenmark Pharmaceuticals Limited
The FDA took a Warning Letter action against Glenmark Pharmaceuticals Limited on Nov 22, 2022 (Colvale, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Glenmark Pharmaceuticals Limited
- Date
- Nov 22, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Colvale (India)